Patents Represented by Attorney LaVonda R. DeWitt

Find this attorney in the Justia Lawyer Directory

  • Phenylxanthine derivatives
    Patent number: 5776940
    Abstract: The present invention relates to novel compounds of formula (I), processes for their preparation, pharmaceutical formulations containing them, and their use in medicine, particularly in the prophylaxis and treatment of septic shock, allergic, and inflammatory conditions, as well as neurodegeneration.
    Type: Grant
    Filed: January 24, 1997
    Date of Patent: July 7, 1998
    Assignee: Glaxo Wellcome Inc.
    Inventors: Susan Mary Daluge, Helen Lyng White
  • Therapeutic benzonitriles
    Patent number: 5723452
    Abstract: The present invention relates to novel compounds of formula (I): ##STR1## or a physiologically functional derivative thereof, pharmaceutical formulations containing them, processes for their preparation and their use in therapy for the prophylaxis or treatment of HIV infection or inflammation are disclosed.
    Type: Grant
    Filed: August 21, 1996
    Date of Patent: March 3, 1998
    Assignee: Glaxo Wellcome Inc.
    Inventor: Joseph Howing Chan
  • Pharmaceutically active benzoquinazoline compounds
    Patent number: 5663337
    Abstract: The present invention relates to benzoquinazoline thymidylate synthase inhibitors, processes for preparing them and pharmaceutical formulations containing them.
    Type: Grant
    Filed: May 25, 1995
    Date of Patent: September 2, 1997
    Assignee: Glaxo Wellcome Inc.
    Inventors: William Pendergast, Scott Howard Dickerson
  • Treatment of cancer with pharmaceutically active benzoquinazoline compounds
    Patent number: 5661155
    Abstract: The present invention relates to bezoquinazoline thymidylate synthase inhibitors, to pharmaceutical formulations containing them and to their use in medicine.
    Type: Grant
    Filed: May 26, 1995
    Date of Patent: August 26, 1997
    Assignee: Glaxo Wellcome Inc.
    Inventors: William Pendergast, Scott Howard Dickerson